Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

COGNITION THERAPEUTICS INC (NASDAQ: CGTX)

 
CGTX Technical Analysis
5
As on 24th Dec 2024 CGTX STOCK Price closed @ 0.62 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.72 & Strong Sell for SHORT-TERM with Stoploss of 1.58 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CGTXSTOCK Price

Open 0.61 Change Price %
High 0.64 1 Day 0.01 1.64
Low 0.60 1 Week 0.14 29.17
Close 0.62 1 Month 0.12 24.00
Volume 1438996 1 Year -1.09 -63.74
52 Week High 2.62 | 52 Week Low 0.38
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
LMDX 0.02 0.00%
LCID 3.20 3.23%
AVGR 1.45 126.56%
NVDA 140.22 0.39%
AKTS 0.04 0.00%
TNXP 0.39 -2.50%
PONO 1.72 2.38%
TELL 1.00 0.00%
TSLA 462.28 7.36%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
GOEV 1.46 1725.00%
CLEU 2.63 1543.75%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
BAOS 8.24 390.48%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
TFFP 0.06 -62.50%
MILEW 0.06 -53.85%
MINM 0.15 -51.61%
LOTZW 0.01 -50.00%
HYZNW 0.01 -50.00%
 
 
CGTX
Daily Charts		 CGTX
Intraday Charts		 Whats New @
Bazaartrend		 CGTX
Free Analysis
 
CGTX Important Levels Intraday
RESISTANCE0.70
RESISTANCE0.67
RESISTANCE0.66
RESISTANCE0.64
SUPPORT0.60
SUPPORT0.58
SUPPORT0.57
SUPPORT0.54
 
CGTX Forecast December 2024
Share
4th UP Forecast1.54
3rd UP Forecast1.25
2nd UP Forecast1.06
1st UP Forecast0.88
1st DOWN Forecast0.36
2nd DOWN Forecast0.18
3rd DOWN Forecast-0.01
4th DOWN Forecast-0.3
 
CGTX Weekly Forecast
4th UP Forecast1.10
3rd UP Forecast0.95
2nd UP Forecast0.85
1st UP Forecast0.76
1st DOWN Forecast0.48
2nd DOWN Forecast0.39
3rd DOWN Forecast0.29
4th DOWN Forecast0.14
 
CGTX Forecast2024
4th UP Forecast5.65
3rd UP Forecast4.04
2nd UP Forecast3.04
1st UP Forecast2.04
1st DOWN Forecast-0.8
2nd DOWN Forecast-1.8
3rd DOWN Forecast-2.8
4th DOWN Forecast-4.41
 
 
CGTX Other Details
Segment EQ
Market Capital 256456800.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CGTX Address
CGTX
 
CGTX Latest News
 
Your Comments and Response on COGNITION THERAPEUTICS INC
 
CGTX Business Profile
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in phase 2 clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed phase 1 clinical trial to treat early-stage Alzheimer's disease; and in preclinical trial to treat dementia with Lewy bodies (DLB) and dry age-related macular degeneration (AMD). The company is also developing CT2168 for the treatment of synucleinopathies, which include DLB and Parkinson's disease; and CT2074 to treat dry AMD. Cognition Therapeutics, Inc. was incorporated in 2007 and is headquartered in Purchase, New York. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service